252 related articles for article (PubMed ID: 18611440)
21. Inhibition of Sphingolipid Synthesis as a Phenotype-Modifying Therapy in Cystic Fibrosis.
Mingione A; Dei Cas M; Bonezzi F; Caretti A; Piccoli M; Anastasia L; Ghidoni R; Paroni R; Signorelli P
Cell Physiol Biochem; 2020 Jan; 54(1):110-125. PubMed ID: 31999897
[TBL] [Abstract][Full Text] [Related]
22. Expression of interleukin-6 in atherosclerotic lesions of male ApoE-knockout mice: inhibition by 17beta-estradiol.
Sukovich DA; Kauser K; Shirley FD; DelVecchio V; Halks-Miller M; Rubanyi GM
Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1498-505. PubMed ID: 9743240
[TBL] [Abstract][Full Text] [Related]
23. Serine protease inhibitor Serp-1 strongly impairs atherosclerotic lesion formation and induces a stable plaque phenotype in ApoE-/-mice.
Bot I; von der Thüsen JH; Donners MM; Lucas A; Fekkes ML; de Jager SC; Kuiper J; Daemen MJ; van Berkel TJ; Heeneman S; Biessen EA
Circ Res; 2003 Sep; 93(5):464-71. PubMed ID: 12919945
[TBL] [Abstract][Full Text] [Related]
24. Disruption of sphingolipid homeostasis by myriocin, a mycotoxin, reduces thymic and splenic T-lymphocyte populations.
Johnson VJ; He Q; Osuchowski MF; Sharma RP
Toxicology; 2004 Sep; 201(1-3):67-75. PubMed ID: 15297021
[TBL] [Abstract][Full Text] [Related]
25. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development.
Guo J; de Waard V; Van Eck M; Hildebrand RB; van Wanrooij EJ; Kuiper J; Maeda N; Benson GM; Groot PH; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1014-9. PubMed ID: 15774908
[TBL] [Abstract][Full Text] [Related]
26. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction.
Dekker MJ; Baker C; Naples M; Samsoondar J; Zhang R; Qiu W; Sacco J; Adeli K
Atherosclerosis; 2013 May; 228(1):98-109. PubMed ID: 23466071
[TBL] [Abstract][Full Text] [Related]
28. Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice.
Bursill CA; Choudhury RP; Ali Z; Greaves DR; Channon KM
Circulation; 2004 Oct; 110(16):2460-6. PubMed ID: 15477414
[TBL] [Abstract][Full Text] [Related]
29. The effect of pomegranate extract on coronary artery atherosclerosis in SR-BI/APOE double knockout mice.
Al-Jarallah A; Igdoura F; Zhang Y; Tenedero CB; White EJ; MacDonald ME; Igdoura SA; Trigatti BL
Atherosclerosis; 2013 May; 228(1):80-9. PubMed ID: 23528829
[TBL] [Abstract][Full Text] [Related]
30. Chronic exposure to the carcinogenic compound benzo[a]pyrene induces larger and phenotypically different atherosclerotic plaques in ApoE-knockout mice.
Curfs DM; Lutgens E; Gijbels MJ; Kockx MM; Daemen MJ; van Schooten FJ
Am J Pathol; 2004 Jan; 164(1):101-8. PubMed ID: 14695324
[TBL] [Abstract][Full Text] [Related]
31. Myriocin-mediated up-regulation of hepatocyte apoA-I synthesis is associated with ERK inhibition.
Glaros EN; Kim WS; Garner B
Clin Sci (Lond); 2010 Mar; 118(12):727-36. PubMed ID: 20102334
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice.
Ozaki M; Kawashima S; Yamashita T; Hirase T; Namiki M; Inoue N; Hirata K; Yasui H; Sakurai H; Yoshida Y; Masada M; Yokoyama M
J Clin Invest; 2002 Aug; 110(3):331-40. PubMed ID: 12163452
[TBL] [Abstract][Full Text] [Related]
33. Effect of fluvastatin sodium on the smooth muscle cells in atherosclerotic plaques. In vivo study using low-density lipoprotein receptor deficient Watanabe heritable hyperlipidemic (WHHL) rabbits.
Shiomi M; Ito T; Tsukada T; Shiraishi M; Yata T
Arzneimittelforschung; 1998 Jun; 48(6):680-5. PubMed ID: 9689427
[TBL] [Abstract][Full Text] [Related]
34. Effects of simvastatin on plasma lipoproteins and hearing loss in apolipoprotein E gene-deficient mice.
Cai Q; Du X; Zhou B; Cai C; Kermany MH; Zhang C; Yoo T
ORL J Otorhinolaryngol Relat Spec; 2009; 71(5):244-50. PubMed ID: 19738398
[TBL] [Abstract][Full Text] [Related]
35. Disodium ascorbyl phytostanyl phosphate reduces plasma cholesterol concentrations and atherosclerotic lesion formation in apolipoprotein E-deficient mice.
Lukic T; Wasan KM; Zamfir D; Moghadasian MH; Pritchard PH
Metabolism; 2003 Apr; 52(4):425-31. PubMed ID: 12701053
[TBL] [Abstract][Full Text] [Related]
36. Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice.
Verschuren L; Kleemann R; Offerman EH; Szalai AJ; Emeis SJ; Princen HM; Kooistra T
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):161-7. PubMed ID: 15514207
[TBL] [Abstract][Full Text] [Related]
37. Low carbohydrate, high protein diet promotes atherosclerosis in apolipoprotein E/low-density lipoprotein receptor double knockout mice (apoE/LDLR(-/-)).
Kostogrys RB; Franczyk-Żarów M; Maślak E; Gajda M; Mateuszuk L; Jackson CL; Chłopicki S
Atherosclerosis; 2012 Aug; 223(2):327-31. PubMed ID: 22771189
[TBL] [Abstract][Full Text] [Related]
38. Hydrogen sulfide regulates vascular endoplasmic reticulum stress in apolipoprotein E knockout mice.
Chen ZF; Zhao B; Tang XY; Li W; Zhu LL; Tang CS; DU JB; Jin HF
Chin Med J (Engl); 2011 Nov; 124(21):3460-7. PubMed ID: 22340159
[TBL] [Abstract][Full Text] [Related]
39. Modulation of plasma lipid levels affects benzo[a]pyrene-induced DNA damage in tissues of two hyperlipidemic mouse models.
Curfs DM; Beckers L; Godschalk RW; Gijbels MJ; van Schooten FJ
Environ Mol Mutagen; 2003; 42(4):243-9. PubMed ID: 14673869
[TBL] [Abstract][Full Text] [Related]
40. Myriocin, a serine palmitoyltransferase inhibitor, blocks cytokinesis in Leishmania (Viannia) braziliensis promastigotes.
Castro EV; Yoneyama KG; Haapalainen EF; Toledo MS; Takahashi HK; Straus AH
J Eukaryot Microbiol; 2013; 60(4):377-87. PubMed ID: 23659342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
